Type of Arrangement and Non-arrangement Transactions [Axis] Exclusive License Agreement [Member] Debt Instrument [Axis] Robert Salna Promissory Note [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings (Deficit) [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Related Party [Axis] Investor [Member] Antidilutive Securities [Axis] Outstanding Options [Member] Outstanding Warrants [Member] Plan Name [Axis] 2015 Long-term Incentive Plan [Member] Exercise Price Range [Axis] Exercise Price 0.55 [Member] Exercise Price 2.00-3.85 [Member] Exercise Price 5.10-7.20 [Member] Exercise Price 0.55-7.20 [Member] Award Date [Axis] 2019 [Member] 2020 [Member] Ownership [Axis] Beneficial Ownership [Member] Series A Preferred Stock [Member] Additional Paid-In-Capital [Member] Accumulated Deficit [Member] Convertible Preferred Stock [Member] Issued and Outstanding Convertible Preferred Stock [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS: Current Assets Cash and cash equivalents Accounts receivables, net Inventory Prepaid expenses Total current assets Other Assets Property and equipment, net Investment in joint venture Total other assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT): Current Liabilities Accounts payable Accrued expenses Accrued expenses (related party) Notes payable net of discount of $0 and $91,428 Total current liabilities Long-term Liabilities, net of current portion Accrued expenses-long-term (related party) Total long-term liabilities, net of current portion Total liabilities Commitments and contingencies STOCKHOLDERS' EQUITY (DEFICIT): Convertible preferred stock, $.001 par value; 5,000,000 shares authorized, 28,000 and no shares issued and outstanding, respectively Common stock, $.001 par value, 100,000,000 shares authorized; 17,015,766 and 12,923,373 shares issued and outstanding, respectively. Additional paid-in capital Accumulated deficit Total stockholder' equity (deficit) Total liabilities and stockholders' equity (deficit) Current notes payable related party, discount Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Net sales Cost of sales Gross profit Operating expenses: Sales and marketing Administrative and general Research and development Depreciation and amortization Total operating expenses Loss from operations Other expense: Interest income Interest expense Gain on disposition of assets Loss on equity method investment in joint venture Total other expense Loss before income taxes Provision for income taxes Net loss Basic and diluted income (loss) per common share Weighted average common shares outstanding, basic and diluted Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation Accretion of notes payable discount Gain on disposition of assets Loss of equity method investment Changes in assets and liabilities: (Increase) in accounts and other receivables Decrease in deferred income (Increase) decrease in prepaid and other assets Increase in inventory Increase (decrease) in accounts payable and accrued expenses Net cash used in operating activities Cash flows from investing activities: Purchase of property and equipment Investment in joint venture Net cash used by investing activities Cash flows from financing activities: Proceeds from sale of common stock Proceeds from sale of preferred stock Payment of offering costs Net cash provided by financing activities Net increase (decrease) in cash Cash and cash equivalents beginning of period Cash and cash equivalents end of period Supplemental disclosure of cash flow information: Interest paid Income taxes paid Accounting Policies [Abstract] Basis of Presentation Significant Accounting Policies Equity [Abstract] Equity Debt Disclosure [Abstract] Notes Payable Share-based Payment Arrangement [Abstract] Stock-Based Compensation Related Party Transactions [Abstract] Related Party Transactions Insurance [Abstract] Lease Obligations Subsequent Events [Abstract] Subsequent Events Earnings (Loss) Per Share Use of Estimates Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity Summary of Option Activity Summary of Warrant Activity Summary of Stock Option and Warrant Outstanding Schedule of Unrecognized Stock-based Compensation Schedule of Lease Rent Obligations Statement [Table] Statement [Line Items] Antidilutive securities potentially dilutive shares Number of common stock issued Number of common stock issued, value Purchase price paid Convertible note payable related parties Equity ownership percentage Sales of equity common stock Sales of common stock price per shares Issuance of common stock gross proceeds Proceeds from issuance of initial public offering Offering costs Conversion of common stock converted Conversion of stock, amount converted Stock conversion price per share Number of common stock issued for services Number of common stock issued for services, value Beginning balance Beginning balance, shares Public offering, net of offering costs of $592,764 Public offering, net of offering costs of $592,764, shares Issuance of Preferred Stock Issuance of Preferred Stock, shares Stock-based compensation expense Conversion of Preferred Stock to Common Conversion of Preferred Stock to Common, shares Issuance of Common Stock for Services Issuance of Common Stock for Services, shares Ending balance Ending balance, shares Debt principal amount Unamortized debt discount Interest expense Interest expense for accretion Aggregate number of common shares reserved Unissued common stock options authorized shares Number of options granted Weighted average fair value of options granted Stock-based compensation expense related to granted Warrants issued Unrecognized stock-based compensation Options Outstanding, Beginning Options Outstanding, Option granted Options Outstanding, Expired Options Outstanding, Forfeited options Options Outstanding, Exercised Options Outstanding, Ending Weighted Average Exercise Price Outstanding, Beginning Weighted Average Exercise Price Options granted Weighted Average Exercise Price Expired Weighted Average Exercise Price Forfeited options Weighted Average Exercise Price Exercised Weighted Average Exercise Price Outstanding, Ending Weighted Average Fair Value Outstanding, Beginning Weighted Average Fair Value Options granted Weighted Average Fair Value Expired Weighted Average Fair Value Forfeited options Weighted Average Fair Value Exercised Weighted Average Fair Value Outstanding, Ending Weighted-average Remaining Contractual Life (years) Outstanding, Beginning Weighted-average Remaining Contractual Life (years) Options granted Weighted-average Remaining Contractual Life (years) Outstanding, Ending Warrant Outstanding, Beginning Warrant Outstanding, Warrants issued Warrant Outstanding, Expired Warrant Outstanding, Forfeited warrants Warrant Outstanding, Exercised Warrant Outstanding, Ending Weighted Average Exercise Price, Beginning Weighted Average Exercise Price, Warrant issued Weighted Average Exercise Price, Expired Weighted Average Exercise Price, Forfeited warrants Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Ending Weighted Average Fair Value, Beginning Weighted Average Fair Value, Warrant issued Weighted Average Fair Value, Expired Weighted Average Fair Value, Forfeited warrants Weighted Average Fair Value, Exercised Weighted Average Fair Value, Ending Weighted-average Remaining Contractual Life (Years), Beginning Weighted-average Remaining Contractual Life (Years), Warrants issued Weighted-average Remaining Contractual Life (Years), Exercised Weighted-average Remaining Contractual Life (Years), Ending Statistical Measurement [Axis] Range of Exercise Prices Range of Exercise Prices Number outstanding Weighted average remaining contractual life Weighted average exercise price Number exercisable Weighted average exercise price exercisable Total Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Accrued royalties Royalty payments, per month Due to related party Area of land Contract lease per month Lease expiration date Rent expenses 2019 2020 Total CAD [Member] Convertible Promissory Note [Member] DNA Logix-Canada [Member] Dr. Brent Satterfield [Member] Dr. Satterfield [Member] Exclusive License Agreement [Member] 0.11-0.55 [Member] 2.00-3.85 [Member] 0.11-7.20 [Member] 5.10-7.20 [Member] Four Companies [Member] Interest expense for accretion. Joint Venture Agreement [Member] Market Licensing Agreement [Member] Nine Employees [Member] Options [Member] Outstanding Options [Member] Outstanding Warrants [Member] Up to $1,000,000 [Member] $1,000,000-$2,000,000 [Member] Above $3,000,000 [Member] $2,000,000-$3,000,000 [Member] Purchase price paid. Robert Salna Promissory Note [Member] Robert Salna Promissory Note Payable [Member] Sales and Marketing [Member] Series A Convertible Preferred Stock [Member] The number of equity-based payment instruments, excluding stock (or unit) options, that were Exercised during the reporting period. Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value. The number of equity-based payment instruments, excluding stock (or unit) options, that were Expired during the reporting period. Share based compensation arrangement by share based payment award equity instruments other than options expired weighted average grant date fair value. Share based compensation arrangement by share based payment award equity instruments other than options weighted average exercised. Share based compensation arrangement by share based payment award equity instruments other than options weighted average Expired. Share based compensation arrangement by share based payment award equity instruments other than options weighted average forfeited. Share based compensation arrangement by share based payment award equity instruments other than options weighted average grant, Weighted-average Remaining Contractual Life (years) Options granted. Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible. Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible. Weighted average grant-date fair value of non-vested other than options outstanding. Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Six Individuals and Four Companies [Member] Summary of Stock Option and Warrant Outstanding [Table Text Block] Three Independent Members [Member] Three Members Our Board of Directors [Member] Two Companies [Member] 2018 [Member] 2015 Long-term Incentive Plan [Member] 2019 [Member] 2020 [Member] Underwriting Agreement [Member] WallachBeth Capital, LLC [Member] Warrants [Member] Payment of deferred offering costs. Beneficial Ownership [Member] Stock conversion price per share. Stock issued during pPeriod value preferred stock. Stock issued during period shares preferred stock. Schedule of convertible preferred stock and stockholders equity [Table Text Block] Issued and Outstanding Convertible Preferred Stock [Member] Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Other Other Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Gain (Loss) on Extinguishment of Debt Gain (Loss) on Sale of Equity Investments Increase (Decrease) in Accounts and Other Receivables Increase (Decrease) in Deferred Income Taxes Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Inventories Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Interest in Joint Venture Net Cash Provided by (Used in) Investing Activities Payments for Repurchase of Initial Public Offering Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Shares, Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.11-7.20 [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Operating Leases, Future Minimum Payments Due